NDC 24979-704

Dexlansoprazole delayed release 60 mg capsule, delayed release

On the label: TWi Pharmaceuticals, Inc..

Japan: 2Italy: 1United States: 1Germany: 1Ireland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
F.i.s. Fabbrica Italiana Sintetici S.p.a.Montecchio Maggiore, ItalyMakes the active ingredient and tests it Problems found, fixed voluntarilyMar 6, 2026 · 7 inspections
Patheon Manufacturing Services LLCGreenville, NC, United StatesMakes it and tests it No problems foundSep 26, 2025 · 11 inspections
Takeda GmbHOranienburg, GermanyMakes it and tests it Problems found, fixed voluntarilyNov 28, 2025 · 7 inspections
Takeda Ireland LimitedBray, IrelandMakes it and tests it Problems found, fixed voluntarilyDec 9, 2022 · 6 inspections
Takeda Pharmaceutical Company LimitedYodogawa-Ku, JapanMakes it and tests it No problems foundApr 12, 2024 · 7 inspections
Takeda Pharmaceutical Company LimitedHikari, JapanMakes the active ingredient and tests it Problems found, fixed voluntarilyNov 6, 2023 · 9 inspections, 1 with FDA action
AbbVie Inc.North Chicago, IL, United StatesPackages it and labels it No problems foundApr 27, 2026 · 19 inspections
AndersonBrecon Inc.Rockford, IL, United StatesTests it, packages it and labels it No problems foundAug 19, 2026 · 11 inspections
Pace Analytical Life Sciences, LLCMorrisville, NC, United StatesTests it No problems foundJul 10, 2026 · 1 inspection

Product details

Generic drug
Dexlansoprazole: every company that makes it
Form
capsule, delayed release
Strength
60 mg
Approval
NDA AUTHORIZED GENERIC NDA022287
On the market since
Jan 1, 2022
Package NDCs
24979-704-06 24979-704-07
Official label
DailyMed (National Library of Medicine), updated Aug 3, 2023

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?